Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	glutathione catabolic process	GGT2P GGTLC3 CHAC1	3.30e-05	11	123	3	GO:0006751
GeneOntologyBiologicalProcess	heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules	LGALS9C FAT4 ADGRL1 TENM4 TENM1	3.70e-05	63	123	5	GO:0007157
Domain	DUF3446	EGR1 EGR2	1.10e-04	3	114	2	PF11928
Domain	DUF3446	EGR1 EGR2	1.10e-04	3	114	2	IPR021849
Domain	AT_hook	KMT2C BAZ2A KMT2A	1.17e-04	16	114	3	PF02178
Domain	Tox-GHH_dom	TENM4 TENM1	2.20e-04	4	114	2	IPR028916
Domain	Tox-GHH	TENM4 TENM1	2.20e-04	4	114	2	PF15636
Domain	Ten_N	TENM4 TENM1	2.20e-04	4	114	2	IPR009471
Domain	Ten_N	TENM4 TENM1	2.20e-04	4	114	2	PF06484
Domain	TENEURIN_N	TENM4 TENM1	2.20e-04	4	114	2	PS51361
Domain	FYrich_C	KMT2C KMT2A	3.65e-04	5	114	2	IPR003889
Domain	FYrich_N	KMT2C KMT2A	3.65e-04	5	114	2	IPR003888
Domain	FYRC	KMT2C KMT2A	3.65e-04	5	114	2	SM00542
Domain	FYRN	KMT2C KMT2A	3.65e-04	5	114	2	SM00541
Domain	YD	TENM4 TENM1	3.65e-04	5	114	2	IPR006530
Domain	FYRN	KMT2C KMT2A	3.65e-04	5	114	2	PF05964
Domain	FYRC	KMT2C KMT2A	3.65e-04	5	114	2	PF05965
Domain	FYRC	KMT2C KMT2A	3.65e-04	5	114	2	PS51543
Domain	FYRN	KMT2C KMT2A	3.65e-04	5	114	2	PS51542
Domain	AT_hook	KMT2C BAZ2A KMT2A	5.82e-04	27	114	3	SM00384
Domain	AT_hook_DNA-bd_motif	KMT2C BAZ2A KMT2A	5.82e-04	27	114	3	IPR017956
Domain	PHD	DIDO1 KMT2C BAZ2A KMT2A	1.15e-03	75	114	4	PF00628
Domain	Znf_PHD-finger	DIDO1 KMT2C BAZ2A KMT2A	1.39e-03	79	114	4	IPR019787
Domain	Znf_FYVE_PHD	DIDO1 KMT2C BAZ2A KMT2A BSN	2.08e-03	147	114	5	IPR011011
Domain	PHD	DIDO1 KMT2C BAZ2A KMT2A	2.16e-03	89	114	4	SM00249
Domain	Znf_PHD	DIDO1 KMT2C BAZ2A KMT2A	2.34e-03	91	114	4	IPR001965
Domain	MAD_homology1_Dwarfin-type	NFIC SMAD1	2.34e-03	12	114	2	IPR003619
Domain	DWA	NFIC SMAD1	2.34e-03	12	114	2	SM00523
Domain	MH1	NFIC SMAD1	2.34e-03	12	114	2	PF03165
Domain	ZF_PHD_2	DIDO1 KMT2C BAZ2A KMT2A	2.74e-03	95	114	4	PS50016
Domain	NHL	TENM4 TENM1	2.76e-03	13	114	2	PS51125
Domain	ZF_PHD_1	DIDO1 KMT2C BAZ2A KMT2A	2.84e-03	96	114	4	PS01359
Domain	-	ARID1A ARID5B	3.68e-03	15	114	2	1.10.150.60
Domain	BRIGHT	ARID1A ARID5B	3.68e-03	15	114	2	SM00501
Domain	ARID_dom	ARID1A ARID5B	3.68e-03	15	114	2	IPR001606
Domain	ARID	ARID1A ARID5B	3.68e-03	15	114	2	PS51011
Domain	ARID	ARID1A ARID5B	3.68e-03	15	114	2	PF01388
Domain	Post-SET_dom	KMT2C KMT2A	4.19e-03	16	114	2	IPR003616
Domain	PostSET	KMT2C KMT2A	4.19e-03	16	114	2	SM00508
Domain	POST_SET	KMT2C KMT2A	4.19e-03	16	114	2	PS50868
Domain	CarboxyPept-like_regulatory	CPD TENM4	4.73e-03	17	114	2	IPR008969
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	ERCC6L MYCBP2 ZCCHC8 SF3A1 CARMIL1 DAB2 DIDO1 NR1D1 NCOR2 EEF2 BAZ2A NFIC TRAPPC10 KMT2A TNKS1BP1 PARD3 MN1 DNM2	4.38e-10	774	126	18	15302935
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	EP400P1 MYCBP2 BICRA CARMIL1 TNRC6B ADGRL1 XIAP CPD TARS2 ARID1A DENND1A ADCY3 KMT2C NCOR2 MICAL2 NFIC KIAA1217 TOX3 ARID5B TNK2 CHD6 GNAS PARD3 AGAP3	7.15e-10	1489	126	24	28611215
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	FOXO1 IRS4 ERCC6L MYCBP2 ZCCHC8 CARMIL1 XIAP DENND1A WDR59 KSR1 BAIAP2L1 USO1 KIAA1217 KMT2A TNKS1BP1 GNAS PARD3 AGAP3	2.34e-09	861	126	18	36931259
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	FOXO1 DYNC2H1 ZCCHC8 PFAS ARID1A NCOR2 ARNT BAIAP2L1 USO1 DROSHA KIAA1217 ARID5B TNKS1BP1 GNAS BSN	4.05e-09	588	126	15	38580884
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	IRS4 WARS1 ERCC6L ZCCHC8 SF3A1 CARMIL1 TNRC6B DIDO1 XIAP PFAS ANKHD1 WDR43 BAZ2A KIAA1217 KMT2A TNKS1BP1 RSBN1L DNM2	8.26e-09	934	126	18	33916271
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	IRS4 ERCC6L MYCBP2 TNRC6B DIDO1 ARID1A ANKHD1 MED15 KMT2C BAZ2A KMT2A TNKS1BP1 PARD3 RSBN1L	1.38e-08	549	126	14	38280479
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	WARS1 POLD2 DIDO1 XIAP GPR183 ANKHD1 ADCY3 TGIF1 STK11 TTBK2 KMT2C SCAP MYPN ARID5B TRAPPC10 PARD3 DNM2 RAD17	7.87e-08	1084	126	18	11544199
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	IRS4 WARS1 MYCBP2 ZCCHC8 SF3A1 DIDO1 PFAS ARID1A ANKHD1 WDR43 BAZ2A KMT2A TNKS1BP1 DNM2	1.18e-07	653	126	14	22586326
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	MYCBP2 TNRC6B KMT2C SCAP TENM4 TNKS1BP1 MINAR1 CHD6 GRIP2	1.45e-07	225	126	9	12168954
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	FOXO1 ERCC6L ZCCHC8 POLD2 DAB2 DENND1A WDR43 KSR1 HROB DROSHA KIAA1217 MYPN AGFG2 TNKS1BP1 GNAS SMAD1 BEGAIN	2.27e-07	1038	126	17	26673895
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	ERCC6L DYNC2H1 BICRA CAT ARID1A MED15 KMT2C NCOR2 BAIAP2L1 RANGRF ARID5B	2.41e-07	398	126	11	35016035
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	FAT4 ERCC6L DYNC2H1 MUC16 ARID1A MED15 TTBK2 NCOR2 PARP4 ARID5B CHD6 BSN DNM2	6.06e-07	638	126	13	31182584
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	EP400P1 ZCCHC8 BICRA TNRC6B XIAP ARID1A ANKHD1 HOXA10 KSR1 NCOR2 ARHGEF33 BAZ2A DROSHA CAPRIN2 PARD3 RSBN1L AGAP3	6.20e-07	1116	126	17	31753913
Pubmed	Interaction network of human early embryonic transcription factors.	BICRA ARID1A MED15 KMT2C NCOR2 ARNT EGR2 NFIC ARID5B KMT2A	6.60e-07	351	126	10	38297188
Pubmed	Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.	MAMLD1 TNRC6B ARID1A ANKHD1 MED15 KMT2C NCOR2 PARP4 ARNT NFIC AGFG2	9.37e-07	457	126	11	32344865
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	WARS1 MYCBP2 BICRA SF3A1 DIDO1 ARID1A MED15 TGIF1 KMT2C NCOR2 EEF2 ARNT EGR1 NFIC KMT2A DNM2	2.56e-06	1103	126	16	34189442
Pubmed	Human Immunodeficiency Virus Type 1 Vpr Mediates Degradation of APC1, a Scaffolding Component of the Anaphase-Promoting Complex/Cyclosome.	IRS4 MYCBP2 POLD2 TNRC6B TARS2 ANKHD1 DROSHA GNAS	3.03e-06	242	126	8	34011540
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	IRS4 MYCBP2 ZCCHC8 TNRC6B ANKHD1 NCOR2 USO1 ARID5B TNKS1BP1 CHD6	3.15e-06	418	126	10	34709266
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	IRS4 BICRA DAB2 NCOR2 BAIAP2L1 EGR1 EGR2 TNK2 BSN SMAD1	4.05e-06	430	126	10	35044719
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	DCHS2 WARS1 MYCBP2 ZCCHC8 ARID1A NR1D1 WDR59 EEF2 MICAL2 DROSHA HPS4 ARID5B CHD6 SNTA1 RSBN1L DNM2 AGAP3	4.15e-06	1285	126	17	35914814
Pubmed	Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.	ZCCHC8 SF3A1 DIDO1 ARID1A BAZ2A NFIC KMT2A TNKS1BP1 RSBN1L	4.54e-06	341	126	9	32971831
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	ERCC6L DIDO1 PFAS TARS2 ANKHD1 CEMIP2 PARP4 ARNT DROSHA KMT2A RSBN1L DNM2	4.61e-06	650	126	12	38777146
Pubmed	Cartography of teneurin and latrophilin expression reveals spatiotemporal axis heterogeneity in the mouse hippocampus during development.	ADGRL1 TENM4 TENM1	5.47e-06	10	126	3	38713721
Pubmed	The OncoPPi network of cancer-focused protein-protein interactions to inform biological insights and therapeutic strategies.	FOXO1 STK11 ARNT NFIC SMAD1	1.11e-05	80	126	5	28205554
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	DAB2 TNRC6B PFAS BAIAP2L1 USO1 MYPN TNKS1BP1	1.18e-05	209	126	7	36779422
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	POLD2 SF3A1 TNRC6B PFAS ARID1A MED15 NCOR2 EEF2 ARNT USO1 MICAL2 TRAPPC10 TNKS1BP1 GNAS PARD3 DNM2	1.19e-05	1247	126	16	27684187
Pubmed	Differential regulation of the zinc finger genes Krox-20 and Krox-24 (Egr-1) suggests antagonistic roles in Schwann cells.	EGR1 EGR2	1.30e-05	2	126	2	9418958
Pubmed	Differential induction of Egr-1 expression in WEHI-231 sublines does not correlate with apoptosis.	EGR1 EGR2	1.30e-05	2	126	2	8344366
Pubmed	Elevated and sustained expression of the transcription factors Egr1 and Egr2 controls NKT lineage differentiation in response to TCR signaling.	EGR1 EGR2	1.30e-05	2	126	2	22306690
Pubmed	TGIF1 is a negative regulator of MLL-rearranged acute myeloid leukemia.	TGIF1 KMT2A	1.30e-05	2	126	2	25349154
Pubmed	A tumorigenic MLL-homeobox network in human glioblastoma stem cells.	HOXA10 KMT2A	1.30e-05	2	126	2	23108137
Pubmed	Role of the teneurins, teneurin C-terminal associated peptides (TCAP) in reproduction: clinical perspectives.	ADGRL1 TENM1	1.30e-05	2	126	2	26485751
Pubmed	Early Growth Response Genes Increases Rapidly After Mechanical Overloading and Unloading in Tendon Constructs.	EGR1 EGR2	1.30e-05	2	126	2	31692087
Pubmed	miRNA-Processing Gene Methylation and Cancer Risk.	TNRC6B DROSHA	1.30e-05	2	126	2	29475968
Pubmed	Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes.	FAT4 ARID1A	1.30e-05	2	126	2	22484628
Pubmed	α-Syntrophin stabilizes catalase to reduce endogenous reactive oxygen species levels during myoblast differentiation.	CAT SNTA1	1.30e-05	2	126	2	28485891
Pubmed	Identification of new human cadherin genes using a combination of protein motif search and gene finding methods.	DCHS2 FAT4	1.30e-05	2	126	2	15003449
Pubmed	TNKS1BP1 mediates AECII senescence and radiation induced lung injury through suppressing EEF2 degradation.	EEF2 TNKS1BP1	1.30e-05	2	126	2	39113018
Pubmed	EGR2 is critical for peripheral naïve T-cell differentiation and the T-cell response to influenza.	EGR1 EGR2	1.30e-05	2	126	2	25368162
Pubmed	The transcription factors Egr1 and Egr2 have opposing influences on adipocyte differentiation.	EGR1 EGR2	1.30e-05	2	126	2	19229250
Pubmed	The Eyes Absent family members EYA4 and EYA1 promote PLK1 activation and successful mitosis through tyrosine dephosphorylation.	BICRA TNRC6B MED15 NCOR2 HROB ARNT	2.02e-05	152	126	6	38360978
Pubmed	The ATG5 interactome links clathrin-mediated vesicular trafficking with the autophagosome assembly machinery.	CARMIL1 DAB2 ANKHD1 NR1D1 DENND1A DNM2 AGAP3	2.19e-05	230	126	7	35449600
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	RELCH DIDO1 ANKHD1 CEMIP2 WDR43 KMT2C HPS4 CAPRIN2 TNKS1BP1 BSN	2.43e-05	529	126	10	14621295
Pubmed	Ex vivo Quantitative Proteomic Analysis of Serotonin Transporter Interactome: Network Impact of the SERT Ala56 Coding Variant.	ADGRL1 CAT EEF2 TRAPPC10 TNK2 PARD3 SNTA1 BEGAIN AGAP3	2.86e-05	430	126	9	32581705
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	IRS4 ZCCHC8 TNRC6B ARID1A DENND1A KSR1 TRAPPC10 PARD3 AGAP3	3.79e-05	446	126	9	24255178
Pubmed	Hydrogen-rich medium protects mouse embryonic fibroblasts from oxidative stress by activating LKB1-AMPK-FoxO1 signal pathway.	FOXO1 STK11	3.90e-05	3	126	2	28743498
Pubmed	Remodeling of the enhancer landscape during macrophage activation is coupled to enhancer transcription.	KMT2C KMT2A	3.90e-05	3	126	2	23932714
Pubmed	Serum response factor regulates immediate early host gene expression in Toxoplasma gondii-infected host cells.	EGR1 EGR2	3.90e-05	3	126	2	21479245
Pubmed	Epidermal-growth-factor-induced proliferation of astrocytes requires Egr transcription factors.	EGR1 EGR2	3.90e-05	3	126	2	19706684
Pubmed	Early growth response transcriptional regulators are dispensable for macrophage differentiation.	EGR1 EGR2	3.90e-05	3	126	2	17312150
Pubmed	Menin is necessary for long term maintenance of meningioma-1 driven leukemia.	KMT2A MN1	3.90e-05	3	126	2	33542482
Pubmed	Gfi1-Mediated Repression of c-Fos, Egr-1 and Egr-2, and Inhibition of ERK1/2 Signaling Contribute to the Role of Gfi1 in Granulopoiesis.	EGR1 EGR2	3.90e-05	3	126	2	30679703
Pubmed	Regulation of insulin-like growth factor binding protein-1 promoter activity by FKHR and HOXA10 in primate endometrial cells.	FOXO1 HOXA10	3.90e-05	3	126	2	12493691
Pubmed	Krox20 hindbrain regulation incorporates multiple modes of cooperation between cis-acting elements.	EGR1 EGR2	3.90e-05	3	126	2	28749941
Pubmed	Mixed lineage leukaemia histone methylases 1 collaborate with ERα to regulate HOXA10 expression in AML.	HOXA10 KMT2A	3.90e-05	3	126	2	25307539
Pubmed	EGR2 Deletion Suppresses Anti-DsDNA Autoantibody and IL-17 Production in Autoimmune-Prone B6/lpr Mice: A Differential Immune Regulatory Role of EGR2 in B6/lpr Versus Normal B6 Mice.	EGR1 EGR2	3.90e-05	3	126	2	35784356
Pubmed	Hepatocyte SREBP signaling mediates clock communication within the liver.	NR1D1 SCAP	3.90e-05	3	126	2	37066875
Pubmed	The Ras/MAPK pathway is required for generation of iNKT cells.	EGR1 EGR2	3.90e-05	3	126	2	21572967
Pubmed	Signaling through retinoic acid receptors is essential for mammalian uterine receptivity and decidualization.	FOXO1 HOXA10 EGR1 SMAD1	4.85e-05	55	126	4	34292881
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	MYCBP2 BICRA ADGRL1 PFAS ARID1A ANKHD1 DENND1A WDR59 KMT2C NCOR2 SCAP TNK2 TNKS1BP1 AGAP3	4.98e-05	1105	126	14	35748872
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	IRS4 TNRC6B CPD ARID1A KIAA1217 TENM1 PARD3	5.13e-05	263	126	7	34702444
Pubmed	A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.	FOXO1 DIDO1 XIAP ARID1A NR1D1 HOXA10 TGIF1 KMT2C ARNT BAZ2A KMT2A	5.70e-05	709	126	11	22988430
Pubmed	Human transcription factor protein interaction networks.	IRS4 BICRA TNRC6B DIDO1 ARID1A ANKHD1 MYO5C MED15 HOXA10 KMT2C NCOR2 ARNT NFIC ARID5B KMT2A CHD6	6.14e-05	1429	126	16	35140242
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	WARS1 CARMIL1 ADGRL1 ARID1A EEF2 TENM4 USO1 MICAL2 KIAA1217 TRAPPC10 KMT2A TNKS1BP1 BSN SNTA1 DNM2 AGAP3	6.25e-05	1431	126	16	37142655
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	ZCCHC8 SF3A1 DIDO1 ARID1A WDR43 ZSCAN29 HOXA10 KMT2C NCOR2 ARNT BAZ2A NFIC ARID5B KMT2A CHD6	7.22e-05	1294	126	15	30804502
Pubmed	SNX27-driven membrane localisation of OTULIN antagonises linear ubiquitination and NF-κB signalling activation.	WARS1 ERCC6L TNRC6B ADGRL1 XIAP ARID1A FCHSD2 ARID5B	7.45e-05	378	126	8	34315543
Pubmed	Cancer gene mutation frequencies for the U.S. population.	ARID1A KMT2C	7.78e-05	4	126	2	34645806
Pubmed	PAX3-FOXO1 controls expression of the p57Kip2 cell-cycle regulator through degradation of EGR1.	FOXO1 EGR1	7.78e-05	4	126	2	17986608
Pubmed	Mouse ten-m/Odz is a new family of dimeric type II transmembrane proteins expressed in many tissues.	TENM4 TENM1	7.78e-05	4	126	2	10225957
Pubmed	Interactions of nuclear receptor coactivator/corepressor proteins with the aryl hydrocarbon receptor complex.	NCOR2 ARNT	7.78e-05	4	126	2	10395741
Pubmed	Agonist-independent GPCR activity regulates anterior-posterior targeting of olfactory sensory neurons.	ADCY3 GNAS	7.78e-05	4	126	2	24034253
Pubmed	HoxA-11 and FOXO1A cooperate to regulate decidual prolactin expression: towards inferring the core transcriptional regulators of decidual genes.	FOXO1 HOXA10	7.78e-05	4	126	2	19727442
Pubmed	MLL1 and DOT1L cooperate with meningioma-1 to induce acute myeloid leukemia.	KMT2A MN1	7.78e-05	4	126	2	26927674
Pubmed	TOX3 deficiency mitigates hyperglycemia by suppressing hepatic gluconeogenesis through FoxO1.	FOXO1 TOX3	7.78e-05	4	126	2	38145825
Pubmed	SET-NUP214 and MLL cooperatively regulate the promoter activity of the HoxA10 gene.	HOXA10 KMT2A	7.78e-05	4	126	2	34320268
Pubmed	The silencing mediator of retinoic acid and thyroid hormone receptors can interact with the aryl hydrocarbon (Ah) receptor but fails to repress Ah receptor-dependent gene expression.	NCOR2 ARNT	7.78e-05	4	126	2	12139968
Pubmed	Circadian lipid synthesis in brown fat maintains murine body temperature during chronic cold.	NR1D1 SCAP	7.78e-05	4	126	2	31451658
Pubmed	An amphioxus Krox gene: insights into vertebrate hindbrain evolution.	EGR1 EGR2	7.78e-05	4	126	2	11180801
Pubmed	EGR1, EGR2, and EGR3 activate the expression of their coregulator NAB2 establishing a negative feedback loop in cells of neuroectodermal and epithelial origin.	EGR1 EGR2	7.78e-05	4	126	2	20506119
Pubmed	A subset of mixed lineage leukemia proteins has plant homeodomain (PHD)-mediated E3 ligase activity.	KMT2C KMT2A	7.78e-05	4	126	2	23129768
Pubmed	Oncogenic All1 fusion proteins target Drosha-mediated microRNA processing.	DROSHA KMT2A	7.78e-05	4	126	2	17581865
Pubmed	Global analysis of H3K4 methylation defines MLL family member targets and points to a role for MLL1-mediated H3K4 methylation in the regulation of transcriptional initiation by RNA polymerase II.	KMT2C KMT2A	7.78e-05	4	126	2	19703992
Pubmed	TRPM1 is a component of the retinal ON bipolar cell transduction channel in the mGluR6 cascade.	GNAS BSN	7.78e-05	4	126	2	19966281
Pubmed	Immediate early genes krox-24 and krox-20 are rapidly up-regulated after wounding in the embryonic and adult mouse.	EGR1 EGR2	7.78e-05	4	126	2	11891986
Pubmed	The MLL3/MLL4 branches of the COMPASS family function as major histone H3K4 monomethylases at enhancers.	KMT2C KMT2A	7.78e-05	4	126	2	24081332
Pubmed	E3 ligases Arf-bp1 and Pam mediate lithium-stimulated degradation of the circadian heme receptor Rev-erb alpha.	MYCBP2 NR1D1	7.78e-05	4	126	2	20534529
Pubmed	The Mll partial tandem duplication: differential, tissue-specific activity in the presence or absence of the wild-type allele.	HOXA10 KMT2A	7.78e-05	4	126	2	18617636
Pubmed	All four members of the Ten-m/Odz family of transmembrane proteins form dimers.	TENM4 TENM1	7.78e-05	4	126	2	12000766
Pubmed	EGR1/2 Inhibits Papillary Thyroid Carcinoma Cell Growth by Suppressing the Expression of PTEN and BAX.	EGR1 EGR2	7.78e-05	4	126	2	33973090
Pubmed	cDNAs with long CAG trinucleotide repeats from human brain.	MED15 NCOR2 TOX3	7.80e-05	23	126	3	9225980
Pubmed	BioID reveals an ATG9A interaction with ATG13-ATG101 in the degradation of p62/SQSTM1-ubiquitin clusters.	RELCH DAB2 CPD DENND1A AGFG2 TRAPPC10 TNK2	8.48e-05	285	126	7	34369648
Pubmed	Defining the membrane proteome of NK cells.	ERCC6L MYCBP2 CAT CPD ADCY3 MED15 KSR1 NCOR2 PARP4 EEF2 USO1 AGFG2 TNK2 GNAS	8.98e-05	1168	126	14	19946888
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	RELCH MYCBP2 DYNC2H1 SF3A1 CARMIL1 ACTR10 XIAP DENND1A MED15 KSR1 TRAPPC10 TNKS1BP1 PARD3 DNM2 AGAP3	9.08e-05	1321	126	15	27173435
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	ZCCHC8 DAB2 DIDO1 WDR43 EEF2 MYPN TNKS1BP1 BEGAIN AGAP3	9.52e-05	503	126	9	16964243
Pubmed	Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation.	IRS4 MYO5C KMT2C CAPRIN2 KMT2A BSN	1.16e-04	208	126	6	33230847
Pubmed	Egr1 mediates p53-independent c-Myc-induced apoptosis via a noncanonical ARF-dependent transcriptional mechanism.	EGR1 EGR2	1.29e-04	5	126	2	21187408
Pubmed	HIV Tat binds Egr proteins and enhances Egr-dependent transactivation of the Fas ligand promoter.	EGR1 EGR2	1.29e-04	5	126	2	11909874
Pubmed	Early growth response proteins (EGR) and nuclear factors of activated T cells (NFAT) form heterodimers and regulate proinflammatory cytokine gene expression.	EGR1 EGR2	1.29e-04	5	126	2	12560487
Pubmed	Corticotropin (ACTH) regulates alternative RNA splicing in Y1 mouse adrenocortical tumor cells.	DAB2 GNAS	1.29e-04	5	126	2	25281401
Pubmed	A genetically determined insertion/deletion related polymorphism in human T cell receptor beta chain (TCRB) includes functional variable gene segments.	TRBV4-3 TRBV4-2	1.29e-04	5	126	2	7931073
Interaction	TLE3 interactions	XIAP ARID1A MED15 NCOR2 ARNT EGR1 EGR2 NFIC ARID5B AGFG2 KMT2A TNKS1BP1 CHD6	4.74e-07	376	122	13	int:TLE3
Interaction	AR interactions	FOXO1 MYCBP2 ZCCHC8 DIDO1 ARID1A MYO5C MED15 TGIF1 KMT2C NCOR2 EEF2 ARNT NFIC KIAA1217 ARID5B KMT2A TNK2 GNAS SMAD1	7.97e-06	992	122	19	int:AR
Interaction	YAP1 interactions	FOXO1 IRS4 SF3A1 TNRC6B DIDO1 ARID1A NR1D1 MED15 KMT2C EEF2 ARNT BAZ2A DROSHA TRAPPC10 KMT2A TNKS1BP1 GNAS PARD3 RSBN1L SMAD1	9.01e-06	1095	122	20	int:YAP1
Interaction	WWTR1 interactions	IRS4 ERCC6L MYCBP2 TNRC6B DIDO1 ARID1A ANKHD1 HOXA10 ARNT KMT2A TNKS1BP1 PARD3	9.90e-06	422	122	12	int:WWTR1
Interaction	GSC interactions	KMT2C NCOR2 ARNT NFIC ARID5B SMAD1	1.47e-05	87	122	6	int:GSC
Interaction	NAA40 interactions	IRS4 WARS1 ERCC6L ZCCHC8 SF3A1 CARMIL1 TNRC6B DIDO1 XIAP PFAS ANKHD1 WDR43 BAZ2A KIAA1217 KMT2A TNKS1BP1 RSBN1L DNM2	2.41e-05	978	122	18	int:NAA40
Interaction	NCOA6 interactions	XIAP MED15 KMT2C NCOR2 EGR2 KMT2A SMAD1	2.90e-05	145	122	7	int:NCOA6
Interaction	FEV interactions	BICRA ARID1A KMT2C NCOR2 ARNT NFIC KMT2A CHD6	3.33e-05	203	122	8	int:FEV
Interaction	SIRT7 interactions	FOXO1 IRS4 WARS1 MYCBP2 ZCCHC8 SF3A1 DIDO1 PFAS ARID1A ANKHD1 WDR43 BAZ2A KMT2A TNKS1BP1 DNM2	4.40e-05	744	122	15	int:SIRT7
Interaction	HNRNPCL2 interactions	ERCC6L MYCBP2 DYNC2H1 WDR43 KSR1 BAZ2A DROSHA RAD17 AGAP3	4.45e-05	274	122	9	int:HNRNPCL2
Interaction	PHF21A interactions	IRS4 MYCBP2 ZCCHC8 TNRC6B ANKHD1 USO1 EGR2 ARID5B TNKS1BP1 CHD6	4.57e-05	343	122	10	int:PHF21A
Interaction	NUP35 interactions	MAMLD1 TNRC6B ARID1A ANKHD1 MED15 KMT2C NCOR2 PARP4 ARNT NFIC AGFG2	5.44e-05	424	122	11	int:NUP35
Interaction	KCNA3 interactions	IRS4 ERCC6L SF3A1 CARMIL1 TNRC6B CPD MYO5C KMT2C EEF2 BAIAP2L1 USO1 CAPRIN2 KMT2A TNKS1BP1 BSN PARD3	7.29e-05	871	122	16	int:KCNA3
Interaction	EGR2 interactions	BICRA ARID1A KMT2C NCOR2 EGR2 NFIC KMT2A	8.27e-05	171	122	7	int:EGR2
Interaction	TEAD1 interactions	ARID1A HOXA10 KMT2C NCOR2 ARNT NFIC ARID5B	9.91e-05	176	122	7	int:TEAD1
Interaction	PAX7 interactions	ARID1A KMT2C NCOR2 ARNT NFIC CHD6	1.09e-04	124	122	6	int:PAX7
Interaction	LYN interactions	IRS4 SF3A1 CARMIL1 ADGRL1 ADCY3 CEMIP2 ARNT BAIAP2L1 KIAA1217 TOX3 KMT2A TNK2 TNKS1BP1 PARD3	1.18e-04	720	122	14	int:LYN
Interaction	CHEK1 interactions	ERCC6L TNRC6B XIAP ARID1A DENND1A MED15 KSR1 RAD17	1.24e-04	245	122	8	int:CHEK1
Interaction	PML interactions	FOXO1 ERCC6L MAMLD1 TNRC6B XIAP MED15 TGIF1 NCOR2 EEF2 ARNT BAIAP2L1 USO1 KMT2A TNKS1BP1 DNM2 AGAP3	1.61e-04	933	122	16	int:PML
Cytoband	Ensembl 112 genes in cytogenetic band chr7q22	UPK3BL2 TFR2 BAIAP2L1 AGFG2 UPK3BL1 STAG3	3.36e-05	219	126	6	chr7q22
Cytoband	7q22.1	BAIAP2L1 AGFG2 UPK3BL1 STAG3	2.76e-04	113	126	4	7q22.1
Cytoband	Ensembl 112 genes in cytogenetic band chr10q21	FAM13C EGR2 MYPN ARID5B	3.26e-04	118	126	4	chr10q21
GeneFamily	Ataxins\|Trinucleotide repeat containing	TNRC6B MED15 NCOR2 TOX3	3.59e-06	25	77	4	775
GeneFamily	PHD finger proteins	DIDO1 KMT2C BAZ2A KMT2A	5.89e-04	90	77	4	88
GeneFamily	CD molecules\|Gamma-glutamyltransferases	GGT2P GGTLC3	1.35e-03	13	77	2	564
GeneFamily	AT-rich interaction domain containing	ARID1A ARID5B	1.81e-03	15	77	2	418
GeneFamily	Cadherin related	DCHS2 FAT4	2.34e-03	17	77	2	24
ToppCell	COVID-19-Epithelial_cells-Airway_club\|COVID-19 / group, cell type (main and fine annotations)	MYO5C DUOX1 BAIAP2L1 KIAA1217 TOX3 SCNN1B TMC5 PARD3	5.48e-08	185	125	8	cfe6fd73d817e173fe803bc1683c291d9bcb8608
ToppCell	COVID-19-Epithelial_cells\|COVID-19 / group, cell type (main and fine annotations)	MYO5C DUOX1 BAIAP2L1 MICAL2 KIAA1217 SCNN1B TMC5 PARD3	6.20e-08	188	125	8	c9cdee6f8d42ee69f5fb335f25084603c511bd29
ToppCell	COVID-19-Epithelial_cells-Airway_goblet\|COVID-19 / group, cell type (main and fine annotations)	MUC16 MYO5C BAIAP2L1 KIAA1217 TOX3 SCNN1B CATSPERB TMC5	6.73e-08	190	125	8	51ca9ef4df3220487152fcf684147730637c7cc1
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MUC16 GMNC KSR1 DUOX1 TENM4 SCNN1B CATSPERB TMC5	8.55e-08	196	125	8	c366f980cc04abfe1c0c14746c11810c812a42c0
ToppCell	COPD-Epithelial-Goblet\|World / Disease state, Lineage and Cell class	MUC16 KIAA1217 TOX3 SCNN1B CATSPERB TMC5 PARD3	9.74e-07	186	125	7	d75fe7640a4b2c450c9759a1b3c3ef2a087f0092
ToppCell	COPD-Epithelial-Goblet\|COPD / Disease state, Lineage and Cell class	MUC16 KIAA1217 TOX3 SCNN1B CATSPERB TMC5 PARD3	1.20e-06	192	125	7	93b2ca0a97776d28c7e8f1a0642c4b63a5554aab
ToppCell	CTRL-Epithelial-Epithelial_cell\|CTRL / Disease state, Lineage and Cell class	NR1D1 BAIAP2L1 KIAA1217 SCNN1B AGFG2 PARD3 CHAC1	1.29e-06	194	125	7	2bc4deaf2a01a39809fc323962fce4286835209c
ToppCell	CTRL-Epithelial\|CTRL / Disease state, Lineage and Cell class	NR1D1 BAIAP2L1 KIAA1217 SCNN1B AGFG2 PARD3 CHAC1	1.29e-06	194	125	7	49dcb31427f370692308f939e23992925708abb7
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_secretory\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MUC16 GMNC KSR1 DUOX1 TENM4 SCNN1B CATSPERB	1.38e-06	196	125	7	b07db4a53ab9be9aad6fae5e45f9547db829d096
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	FAT4 KMT2C KIAA1217 TOX3 KMT2A TNK2 SMAD1	1.58e-06	200	125	7	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	Tracheal-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MUC16 CPD MYO5C BAIAP2L1 KIAA1217 TOX3 TMC5	1.58e-06	200	125	7	d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e
ToppCell	COVID-19\|World / Disease, condition lineage and cell class	MYCBP2 UBALD2 KMT2C ARID5B TRAPPC10 KMT2A GNAS	1.58e-06	200	125	7	7dec470c379cd89f05a0f37c8628b21f136e52f0
ToppCell	Club_cells-SSc-ILD_02\|World / lung cells shred on cell class, cell subclass, sample id	EP400P1 BICRA MAP6D1 KSR1 TMC5 CHAC1	3.74e-06	147	125	6	9211242a8e40d50414d310940616eccce299a7f8
ToppCell	Children_(3_yrs)-Epithelial-lung_goblet_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	LGALS9C ZNF648 KIAA1217 TOX3 SCNN1B TMC5	4.54e-06	152	125	6	1b2a39ae159e79f1fb18d6d164bd7acab5299fca
ToppCell	Control\|World / group, cell type (main and fine annotations)	MYO5C BAIAP2L1 EGR1 MICAL2 TMC5 PARD3	8.05e-06	168	125	6	a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6
ToppCell	Children_(3_yrs)-Epithelial-lung_goblet_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DCHS2 MUC16 KIAA1217 TOX3 SCNN1B TMC5	9.52e-06	173	125	6	464267a2ff3f5c387b6c9c6fa4dab135a221f448
ToppCell	Adult-Epithelial-lung_goblet_cell-D231\|Adult / Lineage, Cell type, age group and donor	LGALS9C DCHS2 MUC16 KIAA1217 TOX3 SCNN1B	9.84e-06	174	125	6	7d2f802f493f19a068e097b2909a9000e2160266
ToppCell	Fetal_29-31_weeks-Epithelial-club_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MYO5C KIAA1217 TOX3 SCNN1B CATSPERB TMC5	1.05e-05	176	125	6	3bbac5c2397535631fce8fa98f6ddb4fe0260351
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC16 MYO5C KSR1 ZNF648 KIAA1217 CATSPERB	1.16e-05	179	125	6	6e965e424eebef50f0202cff75f458be395cfca1
ToppCell	Adult-Epithelial-lung_goblet_cell\|Adult / Lineage, Cell type, age group and donor	LGALS9C DCHS2 MUC16 KIAA1217 TOX3 SCNN1B	1.16e-05	179	125	6	1fc1f252ca943a2f649d1e627f56acbf15f8e058
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FAT4 TOX3 TENM1 GRIP2 PARD3 MN1	1.19e-05	180	125	6	b6efdb4d319ef6f87f559acd974e5a71b06a2322
ToppCell	Control-Epithelial-Goblet\|World / Disease state, Lineage and Cell class	KIAA1217 TOX3 SCNN1B CATSPERB TMC5 PARD3	1.39e-05	185	125	6	9a793e6016295a63820e9d7563f195494ac692e7
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MYCBP2 UBALD2 GPR183 FCHSD2 ARID5B STAG3	1.39e-05	185	125	6	e913c64f9b4873443d88dce270f0b7b6d1b4cbce
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CAT SLC13A2 MYO5C TENM4 BAIAP2L1 MICAL2	1.39e-05	185	125	6	fefaf227d89f680d6f3e91c4a94e26ab4d0dc6c3
ToppCell	Control-Epithelial_cells\|Control / group, cell type (main and fine annotations)	MYO5C DUOX1 BAIAP2L1 MICAL2 TMC5 PARD3	1.53e-05	188	125	6	707ebf76cc6fb600b2f07793cf4ea9482c0de79d
ToppCell	HSPCs-Ery_prog.\|HSPCs / Lineage and Cell class	WDR43 TFR2 EEF2 EGR1 RANGRF BSN	1.57e-05	189	125	6	37d2c45debed1564a40a1085b8b310c50923b9e7
ToppCell	IPF-Epithelial-Goblet\|IPF / Disease state, Lineage and Cell class	KIAA1217 TOX3 SCNN1B CATSPERB TMC5 PARD3	1.62e-05	190	125	6	e41dd5a997ad9952810ffecb57737c03ea1d88b3
ToppCell	IPF-Epithelial-Goblet\|World / Disease state, Lineage and Cell class	KIAA1217 TOX3 SCNN1B CATSPERB TMC5 PARD3	1.62e-05	190	125	6	c29dabf0826663b9d6df51a7af9b76592090e44c
ToppCell	Children_(3_yrs)-Epithelial\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MYO5C DUOX1 MICAL2 KIAA1217 TMC5 PARD3	1.67e-05	191	125	6	e432c6e1ae82dddf84314ce73d2b7a991630d905
ToppCell	Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6\|Hippocampus / BrainAtlas - Mouse McCarroll V32	MYO5C GMNC EGR2 PCDH11X SCNN1B	1.69e-05	113	125	5	6f270b7e59c18243e876311df721e948ce21e850
ToppCell	Epithelial\|World / Lineage, Cell type, age group and donor	MYO5C DUOX1 MICAL2 KIAA1217 TMC5 PARD3	1.72e-05	192	125	6	499e8893afea5e6d3371e0bd018f7e86a524d669
ToppCell	Adult-Epithelial\|Adult / Lineage, Cell type, age group and donor	MYO5C DUOX1 MICAL2 KIAA1217 TMC5 PARD3	1.72e-05	192	125	6	efb962a5fd3b9bdfd8cf8d13c435e29c8271713e
ToppCell	COVID-19-lung-Secretory\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MYO5C BAIAP2L1 KIAA1217 TOX3 SCNN1B TMC5	1.72e-05	192	125	6	59261098ccb52306f837f632ebaea45b90ad30fe
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	KIAA1217 TOX3 PCDH11X TENM1 MINAR1 GRIP2	1.72e-05	192	125	6	dc40ef2341e5d6a6d479f140e023fe1bf687928d
ToppCell	droplet-Tongue-nan-3m-Epithelial\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NR1D1 TGIF1 EEF2 EGR1 ARID5B GNAS	1.77e-05	193	125	6	07ddb9525b686c31fa7df4286557d1e58f7ead52
ToppCell	Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-B_cell\|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	MYCBP2 CARMIL1 TNRC6B FCHSD2 ARID5B STAG3	1.82e-05	194	125	6	ff661419b697aef51a53fdeac8d37d870d65f491
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_secretory\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MUC16 TENM4 KIAA1217 TOX3 SCNN1B TMC5	1.88e-05	195	125	6	e7230a849ea31e6eef9bc6f5468938499450582d
ToppCell	facs-Diaphragm-Limb_Muscle-3m-Mesenchymal-skeletal_muscle_satellite_cell\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TGIF1 EEF2 EGR1 EGR2 ARID5B GNAS	1.93e-05	196	125	6	97ac47daf5bb07fa5dda3976e1ae402750f959b5
ToppCell	356C-Lymphocytic-NK_cells-NK_cell_A\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	CEMIP2 TGIF1 EGR1 EGR2 DEDD2 ARID5B	2.04e-05	198	125	6	ec115c4a5dbc54206c72140aa0c8d6a7c29c5563
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_submucosal-gland\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DCHS2 MUC16 KIAA1217 TOX3 SCNN1B TMC5	2.04e-05	198	125	6	fab3135f03cf23a9f04f0eed543a9dc181f39f5f
ToppCell	Bronchial-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYO5C DUOX1 MICAL2 KIAA1217 TMC5 PARD3	2.10e-05	199	125	6	5f7da3eab58ace6cddb3179a415cd839d5767958
ToppCell	Parenchymal-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYO5C DUOX1 MICAL2 KIAA1217 TMC5 PARD3	2.10e-05	199	125	6	5cea0d9e261903e0eaad60c28a07dff72ce65027
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors\|1_mon / Sample Type, Dataset, Time_group, and Cell type.	FAT4 ARID1A TOX3 KMT2A PARD3 MN1	2.10e-05	199	125	6	358c4b3037f59378db8916a2fbe9ed4830cf1449
ToppCell	Biopsy_Control_(H.)-Epithelial-MUC5AC+_High\|Biopsy_Control_(H.) / Sample group, Lineage and Cell type	LGALS9C MUC16 SLC13A2 ZNF648 TOX3 SCNN1B	2.10e-05	199	125	6	a5240868cea40574ed4ee45eb27a00c1812957ed
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	KIAA1217 TOX3 PCDH11X TENM1 GRIP2 PARD3	2.16e-05	200	125	6	a9cdddc4e985dae59521e557479c24fcc2ac727d
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Duct\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DCHS2 MUC16 KIAA1217 TOX3 SCNN1B TMC5	2.16e-05	200	125	6	b992eeddee38e6fe3564e9b1850f6b20b89bf47d
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6--L3-5\|Neuronal / cells hierarchy compared to all cells using T-Statistic	KIAA1217 TOX3 PCDH11X TENM1 GRIP2 PARD3	2.16e-05	200	125	6	33b9199e0dfc267e2cea20b82d1c167f8adcc635
ToppCell	Bronchus_Control_(B.)-Epithelial-TX-Club\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	MUC16 MYO5C TOX3 SCNN1B CATSPERB TMC5	2.16e-05	200	125	6	292c63693eb7f435335a8cfba07aa35b72139393
ToppCell	Neuronal-Inhibitory-iA-iA_1(SST_PAX6)\|Neuronal / cells hierarchy compared to all cells using T-Statistic	FOXO1 FAT4 TOX3 GRIP2 PARD3 MN1	2.16e-05	200	125	6	d0167f96314be78b6d867bbcc6e4396071d931b8
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)\|Neuronal / cells hierarchy compared to all cells using T-Statistic	KIAA1217 TOX3 PCDH11X TENM1 GRIP2 PARD3	2.16e-05	200	125	6	347a510755374c6a66acee326565dfc447993f18
ToppCell	Neuronal-Inhibitory-iB-iB_3(PVALB-SST)\|Neuronal / cells hierarchy compared to all cells using T-Statistic	KIAA1217 TOX3 TENM1 MINAR1 GRIP2 PARD3	2.16e-05	200	125	6	107854f4855fc99c9f7e737eb246f0d868e6c5fd
ToppCell	Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-SST\|Neuronal / cells hierarchy compared to all cells using T-Statistic	FOXO1 FAT4 TOX3 GRIP2 PARD3 MN1	2.16e-05	200	125	6	53d5e427f0cbf5cf0b63efe4ec01da302f555704
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6\|Neuronal / cells hierarchy compared to all cells using T-Statistic	KIAA1217 TOX3 PCDH11X TENM1 GRIP2 PARD3	2.16e-05	200	125	6	9719fabddc34051949468a7520289e3c750de4f8
ToppCell	Tracheal-NucSeq-Epithelial-Epi_submucosal-gland\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MUC16 CPD MYO5C KIAA1217 TOX3 TMC5	2.16e-05	200	125	6	0eb9ad8c0373bcc62029ec21c590ed03aaacd039
ToppCell	Neuronal-Excitatory-eE(FEZF2_SLC17A7)-eE_2\|Neuronal / cells hierarchy compared to all cells using T-Statistic	DCHS2 FAT4 DAB2 KIAA1217 PCDH11X TENM1	2.16e-05	200	125	6	d31e26387d879ee30731c497cea6aaf4746e40d9
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MYO5C MICAL2 SCNN1B CATSPERB TMC5	6.15e-05	148	125	5	9fe3c0a5904b8e9a0f28130f8d84d4f2a819b06c
ToppCell	droplet-Lung-30m-Hematologic-myeloid-Basophil/Mast_cell-basophil_l14\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TFR2 EGR1 EGR2 C3AR1 BSN	6.97e-05	152	125	5	0fda8980b10ce16179dea92301db74d728f41794
ToppCell	TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Tubular-6\|TCGA-Stomach / Sample_Type by Project: Shred V9	NR1D1 BAIAP2L1 CATSPERB DNM2 CAPN15	8.63e-05	159	125	5	655c0749c238bd68cb797adb83e25a23b8a3cc9d
ToppCell	Children_(3_yrs)-Epithelial-lung_goblet_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MUC16 KIAA1217 TOX3 SCNN1B TMC5	9.15e-05	161	125	5	2d63b279d9a5132e1c09b03930bf9039036d24a2
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW16-Mesenchymal-Cilia-bearing_cell\|GW16 / Sample Type, Dataset, Time_group, and Cell type.	PFAS ARHGEF33 EGR1 KIAA1217 TMC5	9.98e-05	164	125	5	346e1530b4bf30adbcb2f7d64fdfb4cd8df69d7f
ToppCell	COVID-19-Myeloid-MoAM5,_CCL3L1\|Myeloid / Condition, Lineage and Cell class	GPR183 EGR1 EGR2 ARID5B AGAP3	1.12e-04	168	125	5	ea465152ea31391b63c02425beafa9a4f51f6703
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_TBC1D26\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DCHS2 FAT4 DAB2 KIAA1217 PCDH11X	1.15e-04	169	125	5	2abdd8ae9a5d88aac30992142d1b502c959bc015
ToppCell	Immune_cells-B_cell\|Immune_cells / Lineage and Cell class	GPR183 FCHSD2 EGR1 EGR2 C3AR1	1.25e-04	172	125	5	b646894b691a99bf2742bd9da8e578dff0e87f1f
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FAT4 TOX3 GRIP2 PARD3 MN1	1.28e-04	173	125	5	af85fb9f6e26a044ca4d23e5872039b1a7b73b1b
ToppCell	droplet-Lung-LUNG-30m-Myeloid-Basophil\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GPR183 TFR2 ARHGEF33 EGR1 C3AR1	1.28e-04	173	125	5	4f849d236ee358ad30ac977745ac43c8e9778e94
ToppCell	droplet-Lung-LUNG-30m-Myeloid-basophil\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GPR183 TFR2 ARHGEF33 EGR1 C3AR1	1.28e-04	173	125	5	39c3b8313354c4c60764597507a2505dcfa4e8c7
ToppCell	severe-B_memory\|severe / disease stage, cell group and cell class	GPR183 ARID5B TRBV4-2 MINAR1 STAG3	1.28e-04	173	125	5	3a987ac53a0136cc4c70ce8b901a15fc00c795e1
ToppCell	droplet-Thymus-nan-18m-Lymphocytic-DN3_thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TGIF1 RANGRF DROSHA TOX3 BSN	1.28e-04	173	125	5	5d7c53c6d1cdd385e44b79b82faec901747d1736
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DCHS2 DAB2 CEMIP2 KIAA1217 TENM1	1.28e-04	173	125	5	95c723b09254ae7131fe5ba0841472502e83269b
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-5_VIP_KCNJ2\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FAT4 TOX3 GRIP2 PARD3 MN1	1.32e-04	174	125	5	fdadac1eaab2c4a67e4832f0901df22e893add6a
ToppCell	droplet-Thymus-nan-18m-Lymphocytic-Double_negative_thymocyte,_DN3_(Cd8-,_Cd4-),_some_express_pre_TCR_alpha\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TGIF1 RANGRF DROSHA TOX3 BSN	1.32e-04	174	125	5	9eab43885496b8586f8ec5b4bcb1fd5b209218e5
ToppCell	droplet-Lung-30m-Hematologic-myeloid-Basophil/Mast_cell\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	GPR183 TFR2 EGR1 C3AR1 BSN	1.32e-04	174	125	5	e9e4532a474b4b0938a50ff85c9508aca53cd3ae
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DCHS2 CEMIP2 KIAA1217 PCDH11X TENM1	1.32e-04	174	125	5	e4d65fe121a32ac4cdd6312e7b8f867f0852e991
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L5-6_FEZF2_ANKRD20A1\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DCHS2 CEMIP2 KIAA1217 PCDH11X TENM1	1.32e-04	174	125	5	99eb5e1aee136c7039e23b68a43a0fa3d775859f
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW10-Neuronal-GABAergic_neurons\|GW10 / Sample Type, Dataset, Time_group, and Cell type.	TMEM132B TFR2 EGR1 GRIP2 MAGEB17	1.35e-04	175	125	5	d4ff1f197ad4086286e86817cbff24fa718293fc
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DCHS2 CEMIP2 KIAA1217 PCDH11X TENM1	1.43e-04	177	125	5	4c069f0d044a96118090b85ca592a21d6b5d9399
ToppCell	nucseq-Epithelial-Epithelial_Airway-Secretory/RAS\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	KIAA1217 TOX3 SCNN1B CATSPERB TMC5	1.43e-04	177	125	5	779ba86f53650772755b52460be03f18bb204e55
ToppCell	nucseq-Epithelial-Epithelial_Airway-Secretory/RAS-Secretory\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	KIAA1217 TOX3 SCNN1B CATSPERB TMC5	1.43e-04	177	125	5	0f210cfb61b873c5fd77dc17eadf4d017306500e
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DCHS2 CEMIP2 KIAA1217 PCDH11X TENM1	1.43e-04	177	125	5	bde307e67ad8e48a5ff4c0827015f4688f6b3e46
ToppCell	390C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)\|390C / Donor, Lineage, Cell class and subclass (all cells)	DCHS2 MUC16 TOX3 SCNN1B TMC5	1.46e-04	178	125	5	fce60ce6b662f1bdaa3b4da43800c6c22fe89533
ToppCell	390C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-\|390C / Donor, Lineage, Cell class and subclass (all cells)	DCHS2 MUC16 TOX3 SCNN1B TMC5	1.46e-04	178	125	5	b19c906e067b07eadfd68934d9330b447e24c708
ToppCell	COVID-19-Epithelial_cells-AT1\|COVID-19 / group, cell type (main and fine annotations)	MYO5C DUOX1 MICAL2 TMC5 PARD3	1.50e-04	179	125	5	a0b33bd69ffdfd5d38d80207fb40058a490aa19e
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DCHS2 CEMIP2 KIAA1217 PCDH11X TENM1	1.50e-04	179	125	5	7954c0026754ab869b88ab7feb13c2f27d6e272d
ToppCell	Children_(3_yrs)-Epithelial-club_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	EGR1 KIAA1217 TOX3 SCNN1B TMC5	1.54e-04	180	125	5	b509c7d6bdfba672065fb722874bdc68de72ba1c
ToppCell	IPF-Lymphoid-B\|World / Disease state, Lineage and Cell class	TNRC6B CEMIP2 FCHSD2 ARID5B STAG3	1.54e-04	180	125	5	30f9398c9b784f49470847a025bac90687e997a1
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CAT SLC13A2 MYO5C BAIAP2L1 MICAL2	1.54e-04	180	125	5	b798a3fa2dd15b68aa4267f665559527043dcc07
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DCHS2 CEMIP2 KIAA1217 PCDH11X TENM1	1.54e-04	180	125	5	b514c55e52b46e8a1a2f09ed2c59a7683367a505
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	KIAA1217 TOX3 TENM1 MINAR1 GRIP2	1.58e-04	181	125	5	bd7e9437839bca543ca5945df43d6525e6a312a8
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DCHS2 CEMIP2 KIAA1217 PCDH11X TENM1	1.58e-04	181	125	5	08f44323bf71b6004a921bbc969c954c75feeb66
ToppCell	Children_(3_yrs)-Epithelial-lung_goblet_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MUC16 KIAA1217 TOX3 SCNN1B TMC5	1.62e-04	182	125	5	3f1a666fe27dd7529c114539ed5f6b8ca585c875
ToppCell	COVID-19-lung-AT1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MYO5C DUOX1 MICAL2 SCNN1B TMC5	1.67e-04	183	125	5	7b1a385ed54f93bfe85bf0c162e42d05d516b45c
ToppCell	IPF-Lymphoid-B\|IPF / Disease state, Lineage and Cell class	TNRC6B CEMIP2 FCHSD2 ARID5B STAG3	1.67e-04	183	125	5	e37d2c015c34471a8a54a0299e94b0371e1ada5a
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	KIAA1217 TOX3 TENM1 MINAR1 GRIP2	1.67e-04	183	125	5	d2074b13b4831ec18c81273d9a1ff673c3f6a16d
ToppCell	Epithelial-lung_goblet_cell\|World / Lineage, Cell type, age group and donor	MUC16 KIAA1217 TOX3 SCNN1B TMC5	1.67e-04	183	125	5	940cbe298e9c53b5622af09264586ed823d3141f
ToppCell	COVID-19-lung-AT1\|lung / Disease (COVID-19 only), tissue and cell type	MYO5C DUOX1 MICAL2 SCNN1B TMC5	1.67e-04	183	125	5	942530449e9c6583705eeb8f6f12621daea57252
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L5-6_SST_KLHL14\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	IRS4 KIAA1217 TOX3 PCDH11X GRIP2	1.67e-04	183	125	5	439b1d1373b7cc73d65f3b59037a6def7cf8f4ba
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT4 GMNC TENM4 PCDH11X TENM1	1.71e-04	184	125	5	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT4 GMNC TENM4 PCDH11X TENM1	1.71e-04	184	125	5	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT4 GMNC TENM4 PCDH11X TENM1	1.71e-04	184	125	5	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SLC13A2 MYO5C TENM4 BAIAP2L1 MICAL2	1.71e-04	184	125	5	ab2f06906fc7a9931dfa0864ef506832b07fb93e
Drug	Sulfacetamide sodic hydrate [6209-17-2]; Up 200; 15.8uM; MCF7; HT_HG-U133A	FOXO1 TNRC6B ADGRL1 ADCY3 HROB AGFG2 KMT2A TMC5 DNM2 CAPN15	9.52e-08	197	120	10	1695_UP
Drug	LY 294002; Down 200; 10uM; HL60; HT_HG-U133A	DYNC2H1 BICRA NR1D1 HOXA10 NCOR2 HPS4 MINAR1 GNAS CHAC1	8.35e-07	192	120	9	2699_DN
Drug	carbamazepine; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA	TNRC6B ARID1A WDR59 MED15 HROB EGR1 BAZ2A CHAC1	7.39e-06	189	120	8	835_UP
Drug	Hesperidin [520-26-3]; Down 200; 6.6uM; HL60; HT_HG-U133A	MED15 EGR1 BAZ2A NFIC KMT2A TNK2 PARD3 CAPN15	9.64e-06	196	120	8	1294_DN
Drug	Dimethadione [695-53-4]; Down 200; 31uM; HL60; HT_HG-U133A	FOXO1 ARID1A TFR2 KSR1 HROB ARNT STAG3 SMAD1	9.64e-06	196	120	8	3029_DN
Drug	CGX 0596987; Up 200; 20uM; MCF7; HT_HG-U133A	FAM13C SLC13A2 HOXA10 TENM4 MICAL2 AGFG2 SNTA1 CHAC1	9.64e-06	196	120	8	6364_UP
Drug	Stachydrine hydrochloride; Up 200; 22.2uM; HL60; HG-U133A	ARID1A DENND1A ARNT NFIC HPS4 KMT2A DNM2 BEGAIN	1.00e-05	197	120	8	1751_UP
Drug	Piperacetazine [3819-00-9]; Down 200; 9.8uM; MCF7; HT_HG-U133A	ADGRL1 MED15 STK11 EGR1 BAZ2A RANGRF TMC5 PARD3	1.08e-05	199	120	8	7191_DN
Drug	Dinoprost trometamol [38362-01-5]; Down 200; 8.4uM; PC3; HT_HG-U133A	FOXO1 FAT4 TARS2 CEMIP2 MED15 TENM4 GNAS MN1	1.08e-05	199	120	8	6308_DN
Drug	sanguinarine	XIAP CAT ARNT EGR1 DEDD2	1.15e-05	56	120	5	ctd:C005705
Drug	Mbalaa	PFAS CAT	2.75e-05	2	120	2	CID000129474
Drug	Zardaverine [101975-10-4]; Up 200; 15uM; HL60; HT_HG-U133A	FOXO1 GPR183 CEMIP2 MICAL2 AGFG2 TMC5 SNTA1	4.18e-05	176	120	7	2926_UP
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; HL60; HT_HG-U133A	DIDO1 GPR183 ARID1A TGIF1 PARP4 NFIC SMAD1	4.65e-05	179	120	7	1175_DN
Drug	LY 294002; Down 200; 10uM; HL60; HT_HG-U133A	WARS1 PFAS NR1D1 ADCY3 TFR2 HPS4 CHAC1	5.35e-05	183	120	7	2696_DN
Drug	Bisacodyl [603-50-9]; Up 200; 11uM; MCF7; HT_HG-U133A	FAT4 HOXA10 EGR1 BAZ2A KMT2A PARD3 CHAC1	5.35e-05	183	120	7	5677_UP
Drug	Retinoic acid [302-79-4]; Down 200; 13.4uM; HL60; HG-U133A	MYCBP2 PFAS NR1D1 WDR43 MICAL2 ARID5B CHAC1	5.93e-05	186	120	7	1548_DN
Drug	LY 294002; Down 200; 10uM; HL60; HT_HG-U133A	PFAS TFR2 STK11 ARNT MICAL2 SMAD1 CHAC1	6.34e-05	188	120	7	6195_DN
Drug	Rapamycin; Up 200; 0.1uM; PC3; HT_HG-U133A	IRS4 NR1D1 TFR2 KSR1 ARNT TENM1 SCNN1B	7.48e-05	193	120	7	4466_UP
Drug	Podophyllotoxin [518-28-5]; Down 200; 9.6uM; HL60; HT_HG-U133A	FAM13C ADGRL1 PFAS ADCY3 WDR43 EGR1 CHAC1	7.48e-05	193	120	7	2540_DN
Drug	Cimetidine [51481-61-9]; Down 200; 15.8uM; PC3; HG-U133A	SF3A1 DIDO1 CAT TARS2 WDR59 BAZ2A SMAD1	7.73e-05	194	120	7	1884_DN
Drug	Metaraminol bitartrate [33402-03-8]; Down 200; 8.6uM; PC3; HT_HG-U133A	DAB2 NR1D1 CEMIP2 BAZ2A TRAPPC10 GNAS SNTA1	7.98e-05	195	120	7	7368_DN
Drug	Oxalamine citrate salt [1949-20-8]; Up 200; 9.2uM; MCF7; HT_HG-U133A	DYNC2H1 HOXA10 ARNT EGR1 BAZ2A PARD3 SMAD1	7.98e-05	195	120	7	4969_UP
Drug	GSK-3 Inhibitor IX; Down 200; 0.5uM; PC3; HT_HG-U133A	FOXO1 FAT4 WARS1 ADCY3 CEMIP2 ARID5B AGFG2	8.24e-05	196	120	7	6585_DN
Drug	rosiglitazone; Down 200; 10uM; HL60; HT_HG-U133A	DYNC2H1 DIDO1 WDR59 MICAL2 NFIC CHAC1 CAPN15	8.24e-05	196	120	7	1174_DN
Drug	Benfotiamine [22457-89-2]; Up 200; 8.6uM; MCF7; HT_HG-U133A	WDR59 NCOR2 ARNT EGR1 AGFG2 KMT2A TNK2	8.24e-05	196	120	7	3837_UP
Drug	Vigabatrin [60643-86-9]; Down 200; 31uM; HL60; HT_HG-U133A	ERCC6L DYNC2H1 NR1D1 TFR2 HOXA10 EGR1 TNK2	8.51e-05	197	120	7	2452_DN
Drug	Cyproheptadine hydrochloride [969-33-5]; Down 200; 12.4uM; MCF7; HT_HG-U133A	DYNC2H1 MAMLD1 TARS2 MED15 MICAL2 AGFG2 TRAPPC10	8.51e-05	197	120	7	5340_DN
Drug	Iodixanol [92339-11-2]; Up 200; 2.6uM; MCF7; HT_HG-U133A	IRS4 ARID1A HOXA10 MICAL2 AGFG2 MINAR1 GNAS	8.51e-05	197	120	7	3362_UP
Drug	CP-645525-01 [287190-82-3]; Down 200; 10uM; MCF7; HT_HG-U133A	ADCY3 TTBK2 EGR1 HPS4 TMC5 STAG3 DNM2	8.51e-05	197	120	7	7522_DN
Drug	(+)-Isoproterenol (+)-bitartrate salt [14638-70-1]; Down 200; 11uM; PC3; HT_HG-U133A	FAT4 SF3A1 MAMLD1 ADGRL1 ARID1A ARNT TENM1	8.51e-05	197	120	7	6663_DN
Drug	Ifosfamide [3778-73-2]; Up 200; 15.4uM; PC3; HT_HG-U133A	NR1D1 WDR59 TFR2 KSR1 NCOR2 AGFG2 KMT2A	8.78e-05	198	120	7	5805_UP
Drug	Hyoscyamine (L) [101-31-5]; Down 200; 13.8uM; MCF7; HT_HG-U133A	MAMLD1 ADGRL1 CPD NR1D1 MICAL2 AGFG2 PARD3	8.78e-05	198	120	7	5524_DN
Drug	Isoxicam [34552-84-6]; Down 200; 12uM; MCF7; HT_HG-U133A	DYNC2H1 TNRC6B ADCY3 CEMIP2 ARNT SCAP DNM2	8.78e-05	198	120	7	7028_DN
Drug	Rolipram [61413-54-5]; Down 200; 14.6uM; HL60; HT_HG-U133A	TFR2 HOXA10 STK11 ARNT TNK2 MINAR1 CHAC1	8.78e-05	198	120	7	3072_DN
Drug	Aminocaproic acid [60-32-2]; Down 200; 30.4uM; MCF7; HT_HG-U133A	CPD NR1D1 TTBK2 ARNT CAPRIN2 TMC5 CHAC1	8.78e-05	198	120	7	6501_DN
Drug	Retrorsine [480-54-6]; Down 200; 11.4uM; MCF7; HT_HG-U133A	NR1D1 MED15 BAZ2A RANGRF CAPRIN2 CHAC1 DNM2	9.06e-05	199	120	7	4946_DN
Drug	Parbendazole [14255-87-9]; Down 200; 16.2uM; MCF7; HT_HG-U133A	BICRA TNRC6B ADGRL1 ADCY3 STK11 TTBK2 EGR1	9.06e-05	199	120	7	4357_DN
Drug	Palmatine chloride [3486-67-7]; Up 200; 10.4uM; MCF7; HT_HG-U133A	FAT4 NCOR2 EGR1 BAZ2A TNK2 CATSPERB SNTA1	9.06e-05	199	120	7	4957_UP
Disease	Carcinoma, Granular Cell	FAT4 ARID1A HOXA10 STK11 KMT2C EEF2 KMT2A	4.45e-07	116	118	7	C0205644
Disease	Adenocarcinoma, Tubular	FAT4 ARID1A HOXA10 STK11 KMT2C EEF2 KMT2A	4.45e-07	116	118	7	C0205645
Disease	Adenocarcinoma, Oxyphilic	FAT4 ARID1A HOXA10 STK11 KMT2C EEF2 KMT2A	4.45e-07	116	118	7	C0205642
Disease	Carcinoma, Cribriform	FAT4 ARID1A HOXA10 STK11 KMT2C EEF2 KMT2A	4.45e-07	116	118	7	C0205643
Disease	Adenocarcinoma, Basal Cell	FAT4 ARID1A HOXA10 STK11 KMT2C EEF2 KMT2A	4.45e-07	116	118	7	C0205641
Disease	Adenocarcinoma	FAT4 ARID1A HOXA10 STK11 KMT2C EEF2 KMT2A	4.45e-07	116	118	7	C0001418
Disease	Carcinoma, Transitional Cell	ARID1A KMT2C KMT2A CHD6	2.20e-05	41	118	4	C0007138
Disease	Intrahepatic Cholangiocarcinoma	ARID1A KMT2C GNAS	1.19e-04	24	118	3	C0345905
Disease	Extrahepatic Cholangiocarcinoma	ARID1A KMT2C GNAS	1.19e-04	24	118	3	C3805278
Disease	Colorectal Carcinoma	RELCH IRS4 SF3A1 ARID1A STK11 KMT2C ARNT PCDH11X TENM1 SCNN1B GNAS	1.22e-04	702	118	11	C0009402
Disease	Cholangiocarcinoma	ARID1A KMT2C GNAS	1.52e-04	26	118	3	C0206698
Disease	Klatskin's tumor (is_implicated_in)	ARID1A KMT2C	1.57e-04	5	118	2	DOID:4927 (is_implicated_in)
Disease	testosterone measurement	DCHS2 WARS1 ERCC6L ARID1A NCOR2 ARNT BAIAP2L1 EGR1 EGR2 SKOR2 MYPN ARID5B AGFG2 TNKS1BP1 MINAR1	1.76e-04	1275	118	15	EFO_0004908
Disease	Prostatic Neoplasms	FOXO1 ARID1A KMT2C EGR1 USO1 BAZ2A NFIC KMT2A CHD6 PARD3	1.89e-04	616	118	10	C0033578
Disease	Malignant neoplasm of prostate	FOXO1 ARID1A KMT2C EGR1 USO1 BAZ2A NFIC KMT2A CHD6 PARD3	1.89e-04	616	118	10	C0376358
Disease	hyperthyroidism (biomarker_via_orthology)	CAT NR1D1 STK11	1.90e-04	28	118	3	DOID:7998 (biomarker_via_orthology)
Disease	brain disease (implicated_via_orthology)	MYCBP2 DROSHA	2.35e-04	6	118	2	DOID:936 (implicated_via_orthology)
Disease	aflatoxins-related hepatocellular carcinoma (biomarker_via_orthology)	GGT2P GGTLC3	3.29e-04	7	118	2	DOID:5022 (biomarker_via_orthology)
Disease	lung disease (biomarker_via_orthology)	CAT EGR1 C3AR1	3.72e-04	35	118	3	DOID:850 (biomarker_via_orthology)
Disease	HbA1c measurement	WARS1 CARMIL1 PFAS MYO5C TFR2 FCHSD2 HROB NFIC MYPN BSN	3.90e-04	675	118	10	EFO_0004541
Disease	prostate cancer (is_marker_for)	FOXO1 XIAP KMT2C EEF2 KMT2A	4.19e-04	156	118	5	DOID:10283 (is_marker_for)
Disease	colorectal cancer (is_marker_for)	IRS4 ERCC6L XIAP ARID1A EEF2	4.32e-04	157	118	5	DOID:9256 (is_marker_for)
Disease	alcohol dependence (biomarker_via_orthology)	GGT2P GGTLC3	4.37e-04	8	118	2	DOID:0050741 (biomarker_via_orthology)
Disease	Liver Diseases, Parasitic	KMT2C GNAS	5.60e-04	9	118	2	C0023897
Disease	platelet-to-lymphocyte ratio	FOXO1 CARMIL1 TFR2 EGR2 BAZ2A ARID5B TNKS1BP1	6.60e-04	363	118	7	EFO_0008446
Disease	Leukemia, Myelocytic, Acute	FOXO1 GPR183 KMT2C KMT2A MN1	6.71e-04	173	118	5	C0023467
Disease	Pseudohypoaldosteronism, Type I	SCNN1B GNAS	6.99e-04	10	118	2	C0268436
Disease	Pseudohypoaldosteronism	SCNN1B GNAS	6.99e-04	10	118	2	C0033805
Disease	Hyperpotassemia and Hypertension, Familial	SCNN1B GNAS	6.99e-04	10	118	2	C2713447
Disease	Pseudohypoaldosteronism, Type I, Autosomal Recessive	SCNN1B GNAS	6.99e-04	10	118	2	C1449843
Disease	Pseudohypoaldosteronism, Type II	SCNN1B GNAS	6.99e-04	10	118	2	C1449844
Disease	Pseudohypoaldosteronism, Type I, Autosomal Dominant	SCNN1B GNAS	6.99e-04	10	118	2	C1449842
Disease	hematocrit	FOXO1 MAMLD1 TNRC6B PFAS TFR2 TTBK2 NCOR2 EGR2 TOX3 AGFG2 BSN TMC5	7.48e-04	1011	118	12	EFO_0004348
Disease	chronotype measurement	MYCBP2 ZCCHC8 TNRC6B TARS2 DENND1A ADCY3 CEMIP2 DEDD2 SKOR2 BSN BEGAIN	8.38e-04	882	118	11	EFO_0008328
Disease	interleukin-6 measurement, response to stimulus	CARMIL1 MUC16	8.52e-04	11	118	2	EFO_0004810, GO_0050896
Disease	Neuroblastoma	ARID1A CHD6 GNAS	8.89e-04	47	118	3	C0027819
Disease	L2 Acute Lymphoblastic Leukemia	ARNT ARID5B KMT2A	1.07e-03	50	118	3	C0023453
Disease	Childhood Acute Lymphoblastic Leukemia	ARNT ARID5B KMT2A	1.19e-03	52	118	3	C0023452
Disease	neuropsychological test	FAT4 NCOR2 TENM4 KIAA1217 GRIP2	1.20e-03	197	118	5	EFO_0003926
Disease	extracellular matrix protein 1 measurement	TARS2 ARNT	1.20e-03	13	118	2	EFO_0008126
Disease	mean corpuscular hemoglobin concentration	FOXO1 CARMIL1 TNRC6B PFAS TFR2 TGIF1 TTBK2 DEDD2 KIAA1217 MN1 SMAD1 CAPN15	1.60e-03	1105	118	12	EFO_0004528
Disease	Acute Myeloid Leukemia, M1	FOXO1 KMT2C KMT2A MN1	1.62e-03	125	118	4	C0026998
Disease	Acute Myeloid Leukemia (AML-M2)	FOXO1 KMT2C KMT2A MN1	1.62e-03	125	118	4	C1879321
Disease	Malignant Neoplasms	CAT ARID1A STK11 GNAS	1.77e-03	128	118	4	C0006826
Disease	Precursor Cell Lymphoblastic Leukemia Lymphoma	ARNT ARID5B KMT2A	1.89e-03	61	118	3	C1961102
Disease	Fetal Alcohol Syndrome	ERCC6L CAT	2.07e-03	17	118	2	C0015923
Disease	severe acute respiratory syndrome, COVID-19	MAMLD1 MED15 KSR1 KIAA1217 TOX3 PCDH11X PARD3	2.18e-03	447	118	7	EFO_0000694, MONDO_0100096
Disease	creatinine measurement	DAB2 TNRC6B ARID1A DUOX1 MYPN ARID5B TNK2 GNAS BSN PARD3 RSBN1L	2.18e-03	995	118	11	EFO_0004518
Disease	Bladder Neoplasm	ARID1A KMT2C KMT2A CHD6	2.45e-03	140	118	4	C0005695
Disease	Malignant neoplasm of urinary bladder	ARID1A KMT2C KMT2A CHD6	2.52e-03	141	118	4	C0005684
Disease	congenital heart disease (implicated_via_orthology)	KMT2C KMT2A CHD6	2.70e-03	69	118	3	DOID:1682 (implicated_via_orthology)
Disease	stomach cancer (is_implicated_in)	ARID1A KMT2C EEF2	3.04e-03	72	118	3	DOID:10534 (is_implicated_in)
Disease	Hepatitis	FAT4 TGIF1	3.48e-03	22	118	2	HP_0012115

Protein segments in the cluster

Peptide	Gene	Start	Entry
FTAPRTNQDIPAPAN	UPK3BL1	96	B0FP48
APTPNREPANGTNPS	AGAP3	851	Q96P47
QQLFSQGNTFPPTPR	ARNT	581	P27540
QGNTFPPTPRPAENF	ARNT	586	P27540
PPTAFGNSRNLFGQP	CATSPERB	516	Q9H7T0
PNSFGAPEQQPSALE	CAT	406	P04040
PAETFRFPASPGPQQ	BEGAIN	376	Q9BUH8
ESVGFNPSSPPVFNS	ADGRL1	1206	O94910
NRPSAANPCSPVQFS	BAZ2A	1361	Q9UIF9
QSTDPDLPPNQGPFT	FAT4	3531	Q6V0I7
QAQGSPFRSINIPEP	ARHGEF33	136	A8MVX0
PAAPQQQSEPARPSS	DEDD2	176	Q8WXF8
PTVFQPQTFQRPSAD	C3AR1	226	Q16581
FNIDGNNERPSPPPN	ACTR10	231	Q9NZ32
ANFSTNNSNPGARPP	TNK2	921	Q07912
SELPASQPQPFSAQG	RAD17	651	O75943
PSSFAPVSAPRNQTF	EGR2	76	P11161
TFNQPPPDNRSSLGP	RANGRF	141	Q9HD47
PFSPFSSTLQNNPVP	CAPN15	231	O75808
RFPPPQELSQDSFGS	ARID1A	596	O14497
TSPPGAVFPFNFQNE	C8orf88	21	P0DMB2
QLASGPDPAFPRDSQ	DUOX1	196	Q9NRD9
FSNPGNFERQSGTPP	RELCH	131	Q9P260
PENAFSANLNFFPTP	DAB2	276	P98082
SANLNFFPTPNPDPF	DAB2	281	P98082
TTSPLGNPFQSNIFP	DAB2	586	P98082
GNPFQSNIFPAPAVS	DAB2	591	P98082
PPFQDEASSPSSQAP	MUC16	4736	Q8WXI7
QPESDAPQQPGSSPR	NCOR2	1006	Q9Y618
SNANPQSGPPPRVEF	KMT2C	3371	Q8NEZ4
SSSPACQSPPQSFPN	MAGEB17	41	A8MXT2
SFQNPRAVPVQPAFS	LGALS9C	146	Q6DKI2
QQLAPAARSSGFPNP	HPS4	671	Q9NQG7
SGPTAFQQPRFQPPA	BSN	3046	Q9UPA5
TPNTDIFPEPQSQAF	EGR1	211	P18146
PPSANNATFARVPVA	POLD2	16	P49005
NPSPGQRDSRFNFPA	KSR1	476	Q8IVT5
RTPQNFSVPSPGPLN	MED15	496	Q96RN5
PSPTSPGFQFSAQPR	EP400P1	86	Q6ZTU2
ATQLPPRTSAAFPAQ	EP400P1	446	Q6ZTU2
SPQNRFPCQPFQSPS	HROB	291	Q8N3J3
QPPQPAPQATSCSFA	HOXA10	146	P31260
PRQFDASQFSQGPVP	PARP4	1356	Q9UKK3
SASPQPAFQIQPETP	PCDH11X	941	Q9BZA7
QSVFANSDLFPAPPQ	DNM2	816	P50570
TNEFGAPPSPANFIQ	GGTLC3	86	B5MD39
NPFDVFLSPESPTNQ	DCHS2	2041	Q6V1P9
FSQFPQQLTPPRSPS	NR1D1	266	P20393
STRNPNPFIPPDAAS	DYNC2H1	3371	Q8NCM8
SFAPPNTSLNSPSPN	FOXO1	406	Q12778
TAAPNDANGTAKPPF	BAIAP2L1	471	Q9UHR4
NQTPGLQRAFPAPAA	CHD6	1921	Q8TD26
FTPSQDPRTPAGPQF	COL20A1	156	Q9P218
ARLQPPGPSSSSFQN	DYTN	381	A2CJ06
SPTPSAQFPRNDGDP	CHAC1	16	Q9BUX1
FSKPNSPPRPNTQES	C4orf17	316	Q53FE4
LNRSFPDQFSTGEPP	CPD	216	O75976
PSQFETARGPHPNQF	DIDO1	1931	Q9BTC0
QDAQADNPSFPNPRR	ADCY3	551	O60266
PAFLQPQNGNSRHPS	CEMIP2	11	Q9UHN6
NVFPRPTQPFVNSRG	CAPRIN2	846	Q6IMN6
PSPALTQQPQFGPQS	MAMLD1	411	Q13495
FTPNPSAIFQASAPR	MAP6D1	181	Q9H9H5
RPATPNVATPFTPQF	DENND1A	801	Q8TEH3
NVATPFTPQFSFPPA	DENND1A	806	Q8TEH3
PAATQSSFPPNISNP	KMT2A	3166	Q03164
DGQSSPQPSPRTFSQ	CARMIL1	1311	Q5VZK9
PGDPFDNSSRPSQVV	EEF2	821	P13639
PQPFQFQPCDSDTSR	FCHSD2	296	O94868
FSCNNPSTLPRGSQP	GRIP2	401	Q9C0E4
PTPSDFQLQFPPSQG	BICRA	901	Q9NZM4
ASAPVPTDPFQQAQP	C4orf54	1591	D6RIA3
GSNNPTFELQEPSPQ	SLC13A2	171	Q13183
FSAQPRSSQPTQPEP	SCAP	881	Q12770
TNFGFQPDTAPRSPN	SCNN1B	586	P51168
SSCFQNRPPEPASFQ	RHPN1-AS1	26	Q9BWJ2
NDISPPGRFFSSQIP	ERCC6L	1066	Q2NKX8
NEFGAPPSPANFIQP	GGT2P	431	P36268
GRNQSSAFSPPDPAL	MICAL2	1591	O94851
PPSAPASAPQNVFST	PARD3	431	Q8TEW0
LPNPFRSSPLGQNDN	IRS4	811	O14654
PPQPDFQPSQRTSAS	MN1	786	Q10571
PNASSQTPNFPAPER	MINAR1	396	Q9UPX6
SRQLQPPAAPSPQSY	RSBN1L	66	Q6PCB5
FAVQPPGSDRPPSSQ	TARS2	376	Q9BW92
PAIQAAPSFSNSFPQ	WARS1	281	P23381
SRASQKPQPNFPSPE	USO1	591	O60763
TTFSNSPAPNFLPPR	DROSHA	61	Q9NRR4
FTAPRTNQDIPAPAN	UPK3BL2	96	E5RIL1
TPDTPPRSQAQESNY	SIGLEC15	296	Q6ZMC9
QRQPSSPGPTPRNFS	SNTA1	196	Q13424
PGAVQASSPAPLQFF	SUPT20HL1	596	Q3ZLR7
SFPTQGKSPDPNNPS	TMEM132B	871	Q14DG7
PQAQESFSDSNFPLP	GMNC	56	A6NCL1
IGSPSQEAVRPPSNF	GNAS	281	Q5JWF2
QEAVRPPSNFTGSSP	GNAS	286	Q5JWF2
ANNFTPPSATPQGND	GPR183	6	P32249
LSFSPQSQNGRAPPP	KIAA1217	1876	Q5T5P2
QSQNGRAPPPLSFSS	KIAA1217	1881	Q5T5P2
QSSPHNQFTFRPLPP	TENM1	181	Q9UKZ4
SQTPPPSPFSVQAFN	MYCBP2	2681	O75592
RTSQGSPAFQPPEIA	STK11	211	Q15831
QSQRFNLDPESAPSP	FAM13C	246	Q8NE31
GPESQPFISSTPQFR	SPATA31C1	336	P0DKV0
DKSPFNSPSPQDSPR	NFIC	331	P08651
DFQPNEQGNFPPPTT	SF3A1	286	Q15459
TFPDSFQQPNSHPFP	SMAD1	171	Q15797
SLPPAGQASFQAQPT	AGFG2	276	O95081
NPFTAPAAQSPLPST	AGFG2	366	O95081
PSFPTTQPPLANQNE	ARID5B	596	Q14865
FPVRPVNPGNTNSSP	ANKHD1	1891	Q8IWZ3
PPTPPDLNQDFSGFQ	TGIF1	366	Q15583
SQSSESFQFQPPLPP	ZCCHC8	456	Q6NZY4
SDRNFPNSTNLPRNP	XIAP	246	P98170
PAGSSNQPPNLAFLE	STAG3	996	Q9UJ98
PEDPTRPSRFQQQQG	PFAS	286	O15067
QGPPARSPSQDFSFI	TNKS1BP1	1546	Q9C0C2
NSSTSSQFFPRPPPG	TTBK2	1066	Q6IQ55
NRGNFTPRSNPSPAP	TENM4	201	Q6N022
PSQGSEFTPQFPPQS	TOX3	96	O15405
FQPDTLSQPRPGHAN	SKOR2	21	Q2VWA4
ASSNPFALPNSVTPP	WDR59	501	Q6PJI9
LPNPFGPFPNRSSNL	WDR59	761	Q6PJI9
SNTPATPPNFPDALA	UBALD2	66	Q8IYN6
NNSVPSRFSPECPNS	TRBV4-3	76	A0A589
NQDAVLDVPPSFPSN	ZNF648	156	Q5T619
ASSRQPDYPGSQRNP	TMC5	121	Q6UXY8
NFPPETAPFPVSQNS	TRAPPC10	656	P48553
TPQDPNSAAPVVFRS	ZSCAN29	391	Q8IWY8
NNSVPSRFSPECPNS	TRBV4-2	76	A0A539
PSFNQTQFPPVASSG	TFR2	336	Q9UP52
FLAQAQPPTPAATPS	TNRC6B	1726	Q9UPQ9
ANTPATPPNFPDALT	UBALD1	66	Q8TB05
FTTIRPPNESQPFDG	WDR43	216	Q15061
CANFFQENPTPPSPF	MYO5C	586	Q9NQX4
LSFEPNFCQDNPRSP	MYPN	111	Q86TC9
PFTFSIPSGNQFQPR	MYPN	796	Q86TC9